Immunocompetent Alveolus-on-Chip Model for Studying Alveolar Mucosal Immune Responses
- 31 May 2024
- journal article
- research article
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 207,p. e66602
Abstract
We introduce an advanced immunocompetent lung-on-chip model designed to replicate the human alveolar structure and function. This innovative model employs a microfluidic-perfused biochip that supports an air-liquid interface mimicking the environment in the human alveoli. Tissue engineering is used to integrate key cellular components, including endothelial cells, macrophages, and epithelial cells, to create a representative tissue model of the alveolus. The model facilitates in-depth examinations of the mucosal immune responses to various pathogens, including viruses, bacteria, and fungi, thereby advancing our understanding of lung immunity. The primary goal of this protocol is to provide details for establishing this alveolus-on-chip model as a robust in vitro platform for infection studies, enabling researchers to closely observe and analyze the complex interactions between pathogens and the host's immune system within the pulmonary environment. This is achieved through the application of microfluidic-based techniques to simulate key physiological conditions of the human alveoli, including blood flow and biomechanical stimulation of endothelial cells, alongside maintaining an air-liquid interface crucial for the realistic exposure of epithelial cells to air. The model system is compatible with a range of standardized assays, such as immunofluorescence staining, cytokine profiling, and colony-forming unit (CFU)/plaque analysis, allowing for comprehensive insights into immune dynamics during infection. The Alveolus-on-chip is composed of essential cell types, including human distal lung epithelial cells (H441) and human umbilical vein endothelial cells (HUVECs) separated by porous polyethylene terephthalate (PET) membranes, with primary monocyte-derived macrophages strategically positioned between the epithelial and endothelial layers. The tissue model enhances the ability to dissect and analyze the nuanced factors involved in pulmonary immune responses in vitro. As a valuable tool, it should contribute to the advancement of lung research, providing a more accurate and dynamic in vitro model for studying the pathogenesis of respiratory infections and testing potential therapeutic interventions.Keywords
This publication has 11 references indexed in Scilit:
- Mucosal immune responses to infection and vaccination in the respiratory tractImmunity, 2022
- A multi-organ chip with matured tissue niches linked by vascular flowNature Biomedical Engineering, 2022
- Invasive aspergillosis-on-chip: A quantitative treatment study of human Aspergillus fumigatus infectionBiomaterials, 2022
- E-Cadherin: An Important Functional Molecule at Respiratory Barrier Between Defence and DysfunctionFrontiers in Physiology, 2021
- Recent progress on surfactant protein A: cellular function in lung and kidney disease developmentAmerican Journal of Physiology-Cell Physiology, 2020
- Co-infection with Staphylococcus aureus after primary influenza virus infection leads to damage of the endothelium in a human alveolus-on-a-chip modelBiofabrication, 2020
- Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipelineEuropean Journal of Pharmaceutics and Biopharmaceutics, 2019
- Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitroNature Methods, 2015
- Reconstituting Organ-Level Lung Functions on a ChipScience, 2010
- The cell-cell adhesion molecule E-cadherinCellular and Molecular Life Sciences, 2008